Top Buy
| Wertpapier ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | 114,00 € | 150,00 € | 31,58 % |
| AstraZeneca plc | 2 | 0 | 1 | 0 | 144,55 € | 165,00 € | 14,15 % |
| Atossa Genetics Inc | 7 | 1 | 2 | 0 | 1,46 € | 3,74 € | 155,79 % |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | 15,10 € | 23,00 € | 52,32 % |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | 13,85 € | 100,00 € | 622,02 % |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | 8,25 € | 10,00 € | 21,21 % |
| Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | 58,50 € | 66,53 € | 13,72 % |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | 72,86 € | 100,00 € | 37,25 % |
| Bayer AG | 15 | 1 | 1 | 0 | 28,00 € | 50,00 € | 78,57 % |
| BeiGene Ltd ADR | 9 | 1 | 2 | 0 | 160,00 € | 241,54 € | 50,96 % |
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | 6,04 € | 11,05 € | 82,78 % |
| Biogen Inc. | 47 | 1 | 7 | 1 | 208,80 € | 294,45 € | 41,02 % |
| Biolife Solutions Inc | 1 | 0 | 1 | 0 | 19,50 € | - | - |
| Bio-Rad Labs Inc. A | 7 | 0 | 1 | 0 | 266,80 € | 445,58 € | 67,01 % |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | 76,50 € | 75,94 € | -0,74 % |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | 94,56 € | - | - |
| Boston Scientific | 47 | 0 | 10 | 0 | 70,00 € | 73,22 € | 4,60 % |
| Brainstorm Cell | 1 | 0 | 0 | 0 | 0,57 € | - | - |
| Brookdale Sr Lvg | 2 | 0 | 0 | 0 | 6,25 € | 8,27 € | 32,36 % |
| Bruker Corp. | 8 | 1 | 1 | 0 | 70,40 € | 84,02 € | 19,35 % |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | 0,47 € | 1,75 € | 273,13 % |
| Cara Therapeutics Inc. | 10 | 1 | 2 | 0 | 0,70 € | 4,62 € | 563,50 % |
| Catalent Inc. | 1 | 0 | 0 | 0 | 50,63 € | 55,00 € | 8,63 % |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | 15,23 € | 24,13 € | 58,46 % |
| Celldex Therapeutics | 11 | 1 | 2 | 0 | 34,80 € | 56,62 € | 62,69 % |